MenaQ7® is the first and most clinically validated Vitamin K2 as MK-7 (menaquinone-7) available today for bone and cardiovascular health, and patented for cardiovascular health.

MK-7 is recognized in scientific literature for providing optimal activity and vitamin K status in the body, supporting bone and cardiovascular health, and MenaQ7® has demonstrated these strengths and benefits in human clinical trials with adult and child populations.

Meeting the demands of an increasingly growing global market for health solution products, MenaQ7® varieties are suitable for vegans and vegetarians, free from gluten, dairy, and other known allergens.

Since MenaQ7® was first introduced, novel technologies have been pioneered to expand the product portfolio. Today, the MenaQ7® product range caters to a growing global demand of high-purity, stable, and well-researched Vitamin K2 as MK-7.

In addition to MenaQ7® being produced to meet the most stringent quality assurance standards, earning the industry’s highest certifications, the innovation driving the brand was recognized in 2015 when MenaQ7® received the NutrAward for “Best Functional Ingredient” at Natural Products Expo West/Engredea, the largest trade show dedicated to the natural products industry.

To learn more about the key health benefits of MenaQ7® Vitamin K2 as MK-7, click here.

To learn more about the varieties of MenaQ7® Vitamin K2 as MK-7, click here.